Periodic Reporting for period 3 - REFINE (Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices)

REFINE proposes a Regulatory Science Framework for the risk-benefit assessment of medical products and medical devices that are based on nanomedicines and nanobiomaterials (NMBs). Our goal is to demonstrate the relevance of the framework for the most pressing regulatory...